Conditions: Thrombosis, Venous
Keywords: Fondaparinux Hip Replacement Arthroplasty VTE THR MOSLL pentasaccharide Xa factor
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 114
Healthy volunteers: no

Brief summary:
This study is requested by PMDA to confirm the optimal dose for THR (total hip replacement).

Detailed description:

Arms:

Interventions: intervention 1: Fondaparinux
Intervention descriptions: intervention 1: None

Protocol document: